Document Mentions (3 shared documents)

EFTA00811546

2 mentions1 same-page

Page ?Same page

496,454 General Motors Co 12/9/10 97,525 3,585,947 3,406,548 - -3585 947; General Electric Co 4/23/13 23,000 496.109 621,230 -496.10M Gilead Sciences Inc Gilead Sciences Inc 2/5/14 5,000 396 407 353,900 380 450 -15 957 57)14 3,100 246,797 --- 1i9,418 235,879 -10,918! Glaxo Smith Kline PLC

ealized Asset Description Date Cost Value Value Gain (Loss) . . — Haze Trust - Fixed income (DA)3,, -- JP Morgan Chase 7.9% Pfd 4/30/2049 JPM Tr Fit Rate Income Fund 05/10/11 01/22/13 3.000,000 240.973.957 3337.958 2.413,469 3158000 2261,257 3,112,500 2.279,614 -225,458-1 -133,85t Citibank Preferred Ser

EFTA00811539

2 mentions1 same-page

Page ?Same page

1,491 496,454 General Motors Co 12/9/10 97,525 3.585,947 3406548 -3,565,947 General Electric Co 4/23/13 23,000 496,109 621,230 -496,109 Gilead Sciences Inc 2/5/14 5,000 396,407 353 900 380 450 -15,957 Gilead Sciences Inc 3/7/14 3,100 246,797 219,418 235,879 202,600 -10.918 -12,406 'Cie xo

7131/17 Unrealized Asset Description Date i Cost Value Value Gain (Loss) Haze Weer - Fixed Income (DB) JP Morgan Chase 7 9% Pfd 4/30/2049 JPM Tr Fit Rate Income Fund Citibank Preferred Ser C 5.8% Citibank Preferred Ser C 5.8% 05/10/11 01/22/13 3.000.000 240,973.957 -225.458 -133.856 83,332 3937,958 2.41

EFTA00599617

2 mentions1 same-page

Page ?Same page